Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea
ConclusionMutation frequencies and rates should be considered when estimating the POCT usage required to reduce the risk of resistance development in a given population. Molecular POCTs for resistance mutations and stepping-stone mutations to resistance are likely to become important tools in antibiotic stewardship.
Source: Eurosurveillance - Category: Infectious Diseases Authors: Carolin Vegvari, Yonatan H Grad, Peter J White, Xavier Didelot, Lilith K Whittles, Nicole E Scangarella-Oman, Fanny S Mitrani-Gold, Etienne Dumont, Caroline R Perry, Kim Gilchrist, Mohammad Hossain, Tatum D Mortimer, Roy M Anderson and David Gardiner Source Type: research
More News: Cipro | Ciprofloxacin | Gonorrhoea | Infectious Diseases | International Medicine & Public Health | Middle East Health | Oman Health | PET Scan | UK Health